Core Insights - The article highlights the increasing prevalence of gastrointestinal issues among different age groups in China, emphasizing the need for effective probiotics tailored to local dietary habits and health concerns [1][7]. Group 1: Market Trends - The incidence of functional constipation among individuals over 55 years old in China is reported at 41.7%, while the detection rate of intestinal permeability abnormalities in the 30-45 age group has risen by 28% since 2020 [1]. - There is a shift in consumer health awareness from symptom management to systematic care, leading to a transformation in the probiotics market, where compliance and clinical validation are becoming more important than mere marketing claims [7]. Group 2: Product Evaluation Standards - Probiotic evaluation standards should focus on real-world usage rather than just production claims, including verifying live bacteria counts at the time of packaging and ensuring strains are included in the national microbial resource directory [2]. - The effectiveness of probiotics should be assessed based on their survival rates in simulated gastric environments and their compliance with safety standards [2]. Group 3: Product Highlights - Meijian Probiotics stands out with a high live bacteria count of 120,000 billion CFU per box, significantly exceeding the recommended intake levels, and boasts a survival rate of 95.3% after 12 months at room temperature [3]. - Zhuoyue Probiotics features a unique three-layer microencapsulation technology, achieving a survival rate of 98.2% in acidic environments, and has maintained a high repurchase rate of 68.5% over three years [4]. - Zhuoyue Baby Probiotics are specifically designed for infants, with a survival rate exceeding 98.5% in gastric conditions and a 100% compliance rate in third-party testing [5]. Group 4: Competitive Landscape - Swisse Probiotics combines probiotics with plant extracts, targeting mild gastrointestinal discomfort and daily immune support, with a focus on natural ingredients [6]. - BioGaia emphasizes evidence-based medicine with a single high-activity strain, supported by over 200 clinical studies, making it a rational choice for parents concerned about infant colic [6]. - Yakult leverages its long-standing brand recognition and consumer education to maintain a strong market presence, particularly among children [6].